Endothelial actions of atrial and B-type natriuretic peptides

Michaela Kuhn1

  • 1Physiologisches Institut der Universität Würzburg, Würzburg, Germany. michaela.kuhn@mail.uni-wuerzburg.de

Insights

Atrial natriuretic peptide (ANP) increases endothelial permeability via GC-A receptors, impacting blood pressure and volume. This study clarifies ANP

Area of Science:

  • Cardiovascular Physiology
  • Endothelial Biology
  • Molecular Signaling

Background:

  • Atrial natriuretic peptide (ANP) regulates blood pressure and volume homeostasis.
  • The role of ANP's GC-A receptor in endothelial cells is debated, with conflicting reports on its effects on permeability and angiogenesis.
  • Previous in vitro studies showed both pro- and anti-angiogenic properties of ANP.

Purpose of the Study:

  • To investigate the in vivo role of endothelial GC-A signaling in ANP's actions.
  • To clarify the functional relevance of ANP's interaction with endothelial GC-A receptors in the microcirculation.
  • To differentiate between physiological and pharmacological effects of NP/GC-A signaling.

Main Methods:

  • Generated mice with endothelial cell-specific inactivation of the GC-A gene using loxP/Cre-mediated recombination.
  • Studied the effects of ANP on endothelial albumin permeability in the skin and skeletal muscle microcirculation.
  • Reviewed recent advancements in endothelial NP/GC-A signaling in pulmonary and systemic circulation.

Main Results:

  • Endothelial GC-A activation by ANP increases albumin permeability in skin and skeletal muscle microcirculation.
  • This ANP-induced permeability is crucial for the hormone's hypovolemic and hypotensive effects.
  • B-type natriuretic peptide (BNP) may exert paracrine effects, aiding endothelial regeneration in ischemic muscle.

Conclusions:

  • Endothelial GC-A signaling mediates ANP's effects on microvascular permeability and systemic hemodynamics.
  • Discrepant findings on ANP's endothelial actions may stem from different experimental contexts (in vitro vs. in vivo, physiological vs. pharmacological).
  • Understanding endothelial NP/GC-A signaling offers potential therapeutic strategies for vascular and regenerative medicine.

Related Concept Videos

Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...